UK markets closed

Vir Biotechnology, Inc. (VIR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
46.17-1.25 (-2.64%)
As of 11:39AM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close47.42
Bid46.37 x 800
Ask46.51 x 1100
Day's range41.10 - 46.98
52-week range25.31 - 141.01
Avg. volume1,108,222
Market cap6.043B
Beta (5Y monthly)-1.44
PE ratio (TTM)N/A
EPS (TTM)-0.80
Earnings date23 Feb 2022 - 28 Feb 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est77.14
  • Motley Fool

    Why Vir Biotechnology Stock Is Soaring Today

    Shares of Vir Biotechnology (NASDAQ: VIR) were soaring 18.5% as of 11:08 a.m. ET on Tuesday. The big gain came after H.C. Wainwright analyst Patrick Trucchio boosted his price target on Vir from $135 to $200. Several analysts are bullish about Vir's prospects.

  • Motley Fool

    Why Vir Biotechnology Is Up More Than 13% Today

    Shares of biopharma company Vir Biotechnology (NASDAQ: VIR) are up 13.7% as of 11:57 a.m. ET on Monday in response to reports that a new strain of the COVID-19 virus has been identified. Indeed, headlines regarding the new omicron variant of the coronavirus began to surface before Thursday's Thanksgiving holiday. It just took a while for investors to connect the dots all the way back to Vir Biotechnology, which potentially benefits from a renewed outbreak of infections stemming from this new strain of the pandemic-causing virus.